Weekly Rounds: Fighting Cryptococcus Worldwide; Tattoo Infections, and More
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 10, 2023.
Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
ICCC in Uganda: Fighting Cryptococcus Worldwide
Experts from around the world shared new data about cryptococcus at the recent International Conference on Cryptococcus & Cryptococcosis (ICCC) in Uganda.
Hot Topics in IPC: Updates on EzriCare Artificial Tears, the Bird Flu, and COVID-19
Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the latest in the artificial tears infection alert and in the bird flu—and good news for COVID-19—for February 10, 2023.
Is Your Professional Tattoo Artist Protecting You Against Infections?
What should individuals getting a tattoo look for to protect themselves from infection? This is the first article in a series on tattoo safety.
How Long Does C Difficile Linger in a Hospital Room? One Study Shows a Year
Can a patient catch C difficile if the previous hospital room occupant had it?
Do Antidepressants Facilitate Antimicrobial Resistance?
A new study shows antibiotics are not the only widely used pharmaceuticals that can induce the emergence of treatment-resistant bacteria.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
